You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Development and clinical assessment of a robust, 3D printed titanium, myoelectric powered prosthetic digit system
SBC: POINT DESIGNS, LLC Topic: 106ABSTRACT Approximately 600,000 people live with partial hand amputations in the United States, with an estimated 14,500 new cases occurring each year. Despite the advances in miniaturized electronics and motors, there has been very little advancement in mechatronic prosthetic digits for this underserved patient population. In fact, to date, there is only one myoelectric prosthetic option for patie ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Inter-alpha Inhibitors in Hypoxic-Ischemic Brain Injury
SBC: PROTHERA BIOLOGICS, INC. Topic: 105Perinatal brain injury resulting in mental retardation and cerebral palsy is the most severe disability in children and affects 40-148 in preterm and 1–2/1000 in full term infants. This places a huge burden on society, emphasizing the critical need for improved prevention/treatment strategies to decrease perinatal brain injury. Hypothermia (HT) is the only FDA approved therapy to attenuate brain ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Comparative testing of tatCN19o for neuroprotection in rodent tMCAo
SBC: NEUREXIS THERAPEUTICS, INC. Topic: NINDSProject Summary/Abstract Focal cerebral ischemia (stroke) afflicts nearly 800,000 Americans each year and often results in permanent cognitive impairment or death. Efforts in developing a cerebroprotective stroke therapy have largely resulted in disappointment: the only approved pharmacological therapy is hemolytic treatment with tissue plasminogen activator (tPA; alteplase). In this project, we w ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Live spike sorting for multichannel and high-channel recordings
SBC: POPNEURON LLC Topic: 106Project Summary: The goal of this project is to create two prototypes of a novel live spike sorting system which can be used by investigators to spike sort streams of neural data recorded by multi-channel, high channel and ultra-high channel probes. In most in-vivo extracellular recording conditions, an electrode can pick up neural spikes from several nearby neurons resulting in so-called “multi ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
An Interactive Education Program to Reduce High Risk Behavior in Adolescents
SBC: KLEIN BUENDEL, INC. Topic: NICHDInternet-based TRAC (i-TRAC): Interactive Emotion Regulation Skills Training to Improve AdolescentSexual Health Adolescence is a critical developmental period during which behavioral patterns are formed that have powerful influences on current and future health. This is particularly true for sexual behavior, which is affected by the biological changes of puberty as well as normative developmental ...
STTR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
IND-enabling toxicology studies to reach IND approval for a proprietary biologic to treat oral mucositis in cancer patients
SBC: Allander Biotechnologies Topic: NIDCRSummary Oral mucositis, a severe oral ulceration, is a common toxic effect of radio- or chemoradio-therapy (RT or CRT) and a limiting factor to using the optimal dose of radiation for effective cancer treatment. Intensity modulated RT (IMRT) and stereotactic Body RT (SBRT) spare more normal tissues and lessen chronic side effects, but not oral mucosa in head and neck cancer patients. To date, Pali ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Targeting inflammation and oxidative stress to treat acute lung injury with CNP-miR146a
SBC: CERIA THERAPEUTICS INC Topic: NHLBISUMMARYAcute respiratory distress syndrome (ARDS) accounts for 10% of ICU admissions worldwide, with a mortality as high as 46%. ARDS incidence has risen dramatically during the COVID-19 pandemic. Despite improvements in critical care and early detection of lung injury, the management of ARDS remains largely supportive. Although mechanical ventilation may provide the necessary life support, impair ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
The Point Powered: A Robust Actuated Prosthetic Finger for Partial Hand Amputation
SBC: POINT DESIGNS, LLC Topic: NIBIBABSTRACT Approximately 600,000 people live with partial hand limb loss (PHLL) in the United States, with an estimated 14,500 new cases occurring each year. Despite the advances in miniaturized electronics and motors, there has been very little advancement in mechatronic prosthetic digits for this underserved patient population. In fact, to date, there is only one myoelectric prosthetic option for ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
High-Dynamic Target Tracking in Multi-sensor Environments
SBC: NUMERICA CORPORATION Topic: SCO182005The Strategic Capabilities Office (SCO) of OSD is leading a program to demonstrate a Hyper-Velocity Projectile (HVP) Gun Weapon System (HGWS) within the DoD. Emerging missile threats are highly agile, exhibit unpredictable behavior and are often protected by sophisticated counter-measures. To support the deployment of HVP weapon systems for defense against these threats, a comprehensive multi-targ ...
SBIR Phase II 2023 Department of DefenseOffice of the Secretary of Defense -
Filtration Media for In-Home PFAS Removal from Drinking Water
SBC: TDA RESEARCH, INC. Topic: NIEHSProject Summary/Abstract Title Filtration Media for In-Home PFAS Removal from Drinking Water SBIR Phase II Application P.I.: Steven Dietz, TDA Research, Inc. Per- and polyfluoroalkyl substances (PFAS), also commonly known as perfluorinated compounds, are a large family of man-made, globally distributed chemicals that have been used for decades. Perfluorooctanoic acid (PFOA) and perfluorooctane sul ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health